WO2015167213A1 - 빛의 조사를 이용한 지방 분해용 키트 - Google Patents
빛의 조사를 이용한 지방 분해용 키트 Download PDFInfo
- Publication number
- WO2015167213A1 WO2015167213A1 PCT/KR2015/004236 KR2015004236W WO2015167213A1 WO 2015167213 A1 WO2015167213 A1 WO 2015167213A1 KR 2015004236 W KR2015004236 W KR 2015004236W WO 2015167213 A1 WO2015167213 A1 WO 2015167213A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- light
- irradiation
- skin
- less
- kit
- Prior art date
Links
- 230000004130 lipolysis Effects 0.000 title abstract description 22
- 230000005855 radiation Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 claims abstract description 40
- 230000001678 irradiating effect Effects 0.000 claims description 18
- 210000004003 subcutaneous fat Anatomy 0.000 claims description 8
- 239000002537 cosmetic Substances 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 4
- 238000001467 acupuncture Methods 0.000 claims description 3
- 210000000436 anus Anatomy 0.000 claims description 3
- 210000001508 eye Anatomy 0.000 claims description 3
- 239000010408 film Substances 0.000 claims description 3
- 210000004392 genitalia Anatomy 0.000 claims description 3
- 210000000214 mouth Anatomy 0.000 claims description 3
- 210000001519 tissue Anatomy 0.000 claims description 3
- 231100000245 skin permeability Toxicity 0.000 claims 2
- 210000001789 adipocyte Anatomy 0.000 abstract description 66
- 230000007935 neutral effect Effects 0.000 abstract description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 72
- 239000002609 medium Substances 0.000 description 55
- 210000003491 skin Anatomy 0.000 description 34
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 32
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 29
- 239000002953 phosphate buffered saline Substances 0.000 description 29
- 210000004027 cell Anatomy 0.000 description 28
- 230000004069 differentiation Effects 0.000 description 28
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 23
- 239000012091 fetal bovine serum Substances 0.000 description 21
- 230000000694 effects Effects 0.000 description 19
- 102000004877 Insulin Human genes 0.000 description 16
- 108090001061 Insulin Proteins 0.000 description 16
- 229940125396 insulin Drugs 0.000 description 16
- 150000003626 triacylglycerols Chemical class 0.000 description 15
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 12
- 238000012258 culturing Methods 0.000 description 10
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 238000000354 decomposition reaction Methods 0.000 description 6
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 6
- 229960003957 dexamethasone Drugs 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 description 4
- 230000024245 cell differentiation Effects 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 238000002834 transmittance Methods 0.000 description 4
- APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 description 3
- 239000004367 Lipase Substances 0.000 description 3
- 102000004882 Lipase Human genes 0.000 description 3
- 108090001060 Lipase Proteins 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000000593 degrading effect Effects 0.000 description 3
- 235000019421 lipase Nutrition 0.000 description 3
- 230000002366 lipolytic effect Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 239000002041 carbon nanotube Substances 0.000 description 2
- 229910021393 carbon nanotube Inorganic materials 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 230000011759 adipose tissue development Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000020805 dietary restrictions Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009207 exercise therapy Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 238000001126 phototherapy Methods 0.000 description 1
- 210000000229 preadipocyte Anatomy 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0616—Skin treatment other than tanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/203—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser applying laser energy to the outside of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00273—Anchoring means for temporary attachment of a device to tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
- A61B2018/00458—Deeper parts of the skin, e.g. treatment of vascular disorders or port wine stains
- A61B2018/00464—Subcutaneous fat, e.g. liposuction, lipolysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B2018/2005—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser with beam delivery through an interstitially insertable device, e.g. needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N2005/0612—Apparatus for use inside the body using probes penetrating tissue; interstitial probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
Definitions
- the present disclosure relates to kits and slimming methods for breaking down fat.
- Obesity is caused by the energy consumed in excess of energy consumed as fat fat accumulates in fat cells, causing various diseases such as arteriosclerosis, and because it is not cosmetically good, prevention is strongly required. have.
- the present specification is to provide a lipolysis kit for lipolysis by irradiating light to fat cells of the skin or subcutaneous fat layer to enable the lipolysis of fat cells themselves.
- the present specification is a light source irradiation device for irradiating light; And it provides a kit for lipolysis comprising a manual containing a method for decomposing fat by irradiation with light.
- the light may have a wavelength of greater than 600nm to 1500nm or less.
- the light may be visible or infrared light.
- the light may have a pattern that amplifies skin transmittance.
- the manual may include the irradiation intensity of light, the irradiation time of the light, the distance between the irradiation device and the skin, the irradiation method and the irradiation site.
- the irradiation intensity of light may be 1J / cm 2 to 600J / cm 2 .
- the irradiation time of light may be 0.5 minutes to 6 hours. In one embodiment of the present invention, the distance between the irradiation device and the skin may be 0cm to 200cm.
- the irradiation method may be performed by direct irradiation.
- the irradiation method may be performed through an auxiliary means capable of contacting the skin.
- the auxiliary means may be one or more selected from the group consisting of filters, sheets, films, cosmetics, gels and creams.
- the irradiation method may be performed using one or more selected from the group consisting of a needle, a cannula, and a microneedle.
- the irradiated site may be any skin tissue that can accumulate fat except the eye, mouth, genitals, anus.
- the present disclosure provides a slimming method comprising irradiating light to the skin.
- the light may be the intensity of 1J / cm 2 to 600J / cm 2.
- the irradiation may be for 0.5 minutes to 6 hours of irradiation.
- the irradiation may be performed at a position where the distance from the skin is 0 cm to 200 cm.
- the irradiation may be performed by direct irradiation.
- the irradiation may be carried out through an auxiliary means capable of contacting the skin.
- the irradiation may be to irradiate the skin subcutaneous fat layer with light.
- the skin subcutaneous fat layer may comprise adipocytes or differentiated adipocytes that are in the course of differentiation or differentiation.
- the irradiation may be to break down triglycerides (Triglyceride) of adipocytes into glycerol (Glycerol).
- the conventional lipolysis method by irradiating light of a wavelength of light harmless to the body to decompose triglycerides in fat cells can safely and effectively decompose fat, the conventional lipolysis method It is more economical and simpler and can be applied to slimming methods.
- Figure 1 is a measurement of the total triglycerides (Total TG) and serum glycerol (Serum Glycerol) amount in the media eluted from adipocytes after a specific wavelength light treatment of the light region according to an embodiment of the present invention at all stages of cell differentiation The result is.
- Figure 2 is a result of measuring the total triglyceride and serum glycerol amount in the medium eluted from the adipocytes after a specific wavelength light treatment of the light region according to an embodiment of the present invention to the final differentiated adipocytes.
- Figure 3 is a result of measuring the residual triglycerides (TG contents) in the adipocytes after a specific wavelength light treatment of the light region in accordance with an embodiment of the present invention after the final differentiated adipocytes.
- Korean Patent Application No. 10-2014-0052315 filed April 30, 2014, is incorporated herein by reference in its entirety for all purposes. This application also claims the benefit of Korean Patent Application No. 10-2014-0052315, which is hereby incorporated by reference in its entirety.
- the present specification is a light source irradiation device for irradiating light; And it provides a kit for lipolysis comprising a manual containing a method of decomposing fat by irradiation with light.
- the light may be visible light or infrared light.
- the light source irradiation device is a power supply; An input unit; A light source unit; sensor; Control unit; And a display unit, but is not limited thereto.
- the input unit may be one capable of inputting light intensity, irradiation time, wavelength of light, and pattern of light as required for irradiation.
- the light source unit may be one in which light is generated and irradiated.
- the sensor includes various kinds of things, and may be for measuring the distance between the irradiation device and the skin.
- the controller may control light irradiation through the light source unit as input to the input unit.
- the display unit may display a content input through the input unit and a distance from the skin.
- the light source unit may include a solar light transmitting material.
- the solar light transmitting material can be used as long as it transmits the light, for example, a band pass that transmits only a quartz plate or a target ray region.
- a band pass filter may be used, but is not limited thereto.
- the light source unit LED (light emitting diode), OLED (organic light emitting diode), LD (laser diode), laser, electrodeless lamp, CNT (carbon nanotube), CCFL (cold cathode fluorescent lamp), FFL (Light Source Lamp), EEFL (External Electrode Fluorescent Lamp), Incandescent Lamp, Halogen Lamp, Fluorescent Lamp, Tungsten Lamp, Low Pressure / High Pressure Sodium Lamp, Low Pressure / High Pressure Mercury Lamp, Clenon Lamp, Metal Halide Lamp, HID Lamp, Remote light source illumination (optical fiber, prism light), xenon arc lamp, etc. may be used, but is not limited thereto.
- the light source irradiating device means any device capable of emitting light, and although it is not intended to irradiate light, a person skilled in the art to which the specification belongs can easily change and irradiate light. It also includes a device that can.
- the light source irradiating device may be a phototherapy device used in a hospital or a clinic, or may be a personal or portable light irradiation device.
- the manual may include the irradiation intensity of light, the irradiation time of the light, the distance between the irradiation device and the skin, the irradiation method and the irradiation site.
- the manual may include information for adjusting one or more of the irradiation intensity of the light, the irradiation time, the distance to the skin according to the user's state.
- the irradiation intensity of light may be 1J / cm 2 to 600J / cm 2 .
- the irradiation time of light may be 0.5 minutes to 6 hours. If the irradiation intensity is less than 1 J / cm 2 or the irradiation time is less than 0.5 minutes, the effect of the irradiation may be insignificant. If the irradiation intensity is more than 600 J / cm 2 or the irradiation time is more than 6 hours, the irradiation It can damage the skin.
- the irradiation intensity of light is 1J / cm 2 or more, 10J / cm 2 or more, 50J / cm 2 or more, 100J / cm 2 or more, 150J / cm 2 or more, 200J / cm 2 or more, or 250J / cm 2 or more It may be, but is not limited thereto.
- Irradiation intensity of the light in the present specification is 600J / cm 2 or less, 550J / cm 2 or less, 500J / cm 2 or less, 450J / cm 2 or less, 400J / cm 2 or less, 350J / cm 2 or less, or 300J / cm 2 or less days May be, but is not limited thereto.
- the light irradiation time may be at least 10 minutes, at least 30 minutes, at least 1 hour, at least 1 hour 30 minutes, at least 2 hours, or at least 2 hours 30 minutes, but is not limited thereto. In the present specification, the light irradiation time may be 5 hours 30 minutes or less, 5 hours or less, 4 hours 30 minutes or less, 4 hours or less, 3 hours 30 minutes or less, or 3 hours or less, but is not limited thereto.
- the distance between the irradiation device and the skin means the distance between the light source unit of the irradiation device and the skin by a sensor provided in the irradiation device, and in one embodiment of the present invention, the distance between the irradiation device and the skin may be 0 cm to 200 cm. have. If the distance from the skin is less than 0 cm, the skin does not come into contact but penetrates. If the distance is more than 200 cm, the effect of irradiation may be insignificant.
- the distance between the irradiation device and the skin may be 5 cm or more, 10 cm or more, 15 cm or more, 20 cm or more, 25 cm or more, 30 cm or more, 35 cm or more, 40 cm or more, or 45 cm or more, but is not limited thereto.
- the distance between the irradiation device and the skin may be 170 cm or less, 140 cm or less, 110 cm or less, 80 cm or less, 75 cm or less, 70 cm or less, 65 cm or less, 60 cm or less, or 55 cm or less, but is not limited thereto.
- the irradiation method may be carried out by direct irradiation or via one or more auxiliary means selected from the group consisting of filters, sheets, films, cosmetics, gels and creams.
- the irradiation method may also be performed using one or more selected from the group consisting of acupuncture, cannula, and microneedles.
- the irradiated site may be any skin tissue where fat can accumulate except for the eye, mouth, genitals and anus.
- the present specification provides a slimming method comprising irradiating light to the skin or subcutaneous fat layer thereof.
- the term “slimming” may mean that the circumference or thickness of a body or a portion of a portion thereof is relatively small compared to its elongation or length. This "slimming” can also be a slimming, weight loss, or slimming of the body or a portion of the body, and weight loss in the process.
- adipocytes are generally used adipocytes, and are not limited as long as they are cells storing fat. Includes differentiated cells, undifferentiated cells, and cells in differentiation.
- the skin comprises the epidermis, dermis and subcutaneous fat layer and the fat cells present in each layer may be the subject of light irradiation herein.
- the light is not limited as long as it is a light ray corresponding to the wavelength of the entire light region.
- the light may be the wavelength of the light alone except heat. Only the wavelength of light can promote lipolysis.
- Irradiation light used in the present specification may be one having a wavelength of more than 600nm to 1500nm even in the light region, specifically, in the present specification, light may have a real number in the range of more than 600nm to 1500nm or less as the wavelength.
- the light region is greater than 600 nm, more than 605 nm, more than 610 nm, more than 615 nm, more than 620 nm, more than 625 nm, more than 630 nm, more than 640 nm, more than 641 nm, more than 643 nm, more than 645 nm, more than 647 nm, more than 649 nm, more than 650 nm, more than 660 nm.
- the light region is 2000 nm or less, 1600 nm or less, 1500 nm or less, 1450 nm or less, 1400 nm or less, 1350 nm or less, 1300 nm or less, 1250 nm or less, 1200 nm or less, 1150 nm or less, 1100 nm or less, 1050 nm or less, 1000 nm or less, 950 nm or less, 900 nm or less 850 nm or less, 800 nm or less, 790 nm or less, 770 nm or less, 750 nm or less, 730 nm or less, 710 nm or less, 700 nm or less, 690 nm or less, 680 nm or less, 670 nm or less, 660 nm or less, 650 nm or less, 648 nm or less, 646 nm or less, 644 nm or less 640 nm or
- the light may have a value of the wavelength described above as the maximum energy wavelength ( ⁇ max).
- the light may have a wavelength region of ⁇ 100nm based on the ⁇ max of the light. More specifically, in one aspect of the invention, the light is ⁇ 90nm or less, ⁇ 80nm or less, ⁇ 70nm or less, ⁇ 60nm or less, ⁇ 50nm or less, ⁇ 40nm or less, ⁇ 30nm or less, based on the ⁇ max of the light, It may have a wavelength range of ⁇ 20nm or less, ⁇ 10nm or less, or ⁇ 5nm or less.
- the wavelength of light exceeds 600nm to 700nm when lambda max is 660nm; 700 nm to 800 nm when lambda max is 740 nm; 800 nm to 900 nm when lambda max is 850 nm; 900 nm to 1,000 nm when lambda max is 940 nm; 1,000 nm to 1,100 nm when lambda max is 1,050 nm; 1,100 nm to 1,200 nm when lambda max is 1,150 nm; 1,200 nm to 1,300 nm when lambda max is 1,250 nm;
- ⁇ max is 1,350 nm, it may be an area of 1,300 nm to 1,400 nm.
- the maximum energy wavelength refers to a wavelength having the highest energy among lights having a wavelength of a specific region.
- ⁇ max means a wavelength at the highest peak when the wavelength range of light exists in the same bell shape as a normal distribution graph in which the x axis is the wavelength and the y axis is the energy of the light.
- the portion indicated by the dotted line means ⁇ max.
- the irradiation may inhibit the fat formation process of the adipocytes in the step of passing from the undifferentiated adipocytes to the differentiated cells or in the middle of the differentiation or break down the produced fat, and the fat after the differentiation is completed Can break down fat in cells All the light irradiation before, during, and after the differentiation of adipocytes can confirm the effect of inhibiting or degrading fat formation, and when applying light to the skin or subcutaneous fat layer, various differentiation stages present in the skin It has a lipolytic effect on several fat cells in.
- irradiation may be carried out on the skin or its subcutaneous fat layer prior to or during adipocyte differentiation. When carried out during the differentiation process, it is irrelevant at any time during the differentiation process, irradiation may be carried out only once, and may be carried out two or more times.
- irradiating the undifferentiated cells of adipocytes with light in Phosphate Buffered Saline (PBS) medium Culturing the adipocytes in a cocktail medium for differentiation for 1 to 3 days and then irradiating the adipocytes with light in PBS (Phosphate Buffered Saline) medium again; Irradiating the adipocytes with insulin in PBS (Phosphate Buffered Saline) medium after incubation for 2 to 4 days in insulin medium; And culturing the adipocytes in FBS (fetal bovine serum) medium for 1 to 3 days.
- PBS Phosphate Buffered Saline
- FBS fetal bovine serum
- culturing the undifferentiated cells of adipocytes for 1 to 3 days and then irradiating with light in PBS (Phosphate Buffered Saline) medium After culturing the adipocytes in a cocktail medium for differentiation for 1 to 3 days, after culturing for 2 to 4 days in insulin medium, culturing for 1 to 3 days in FBS (fetal bovine serum) medium; but may include; It is not limited to this.
- PBS Phosphate Buffered Saline
- adipocytes In addition, after culturing the undifferentiated cells of adipocytes for 1 to 3 days, incubated for 1 to 3 days in a differentiation cocktail medium and then irradiated with light in PBS (Phosphate Buffered Saline) medium; And culturing the adipocytes in insulin medium for 2 to 4 days and incubating for 1 to 3 days in FBS (fetal bovine serum) medium.
- PBS Phosphate Buffered Saline
- FBS fetal bovine serum
- adipocytes In addition, after incubating the undifferentiated cells of adipocytes for 1 to 3 days, incubated for 1 to 3 days in a cocktail medium for differentiation, then incubated for 2 to 4 days in insulin medium, and then again with light in PBS (Phosphate Buffered Saline) medium Investigating; And culturing the adipocytes in FBS (fetal bovine serum) medium for 1 to 3 days.
- PBS Phosphate Buffered Saline
- FBS fetal bovine serum
- irradiation may be performed after completion of adipocyte differentiation.
- adipocytes after culturing the undifferentiated cells of adipocytes for 1 to 3 days, incubated for 1 to 3 days in differentiation cocktail medium, incubated for 2 to 4 days in insulin medium, 1 to 3 in FBS (fetal bovine serum) medium Incubating for 3 days; And irradiating the adipocytes with light in PBS (Phosphate Buffered Saline) medium.
- PBS Phosphate Buffered Saline
- adipocytes As the undifferentiated cells of adipocytes are cultured in a cocktail medium, insulin medium, and FBS medium, cell differentiation is completed to become differentiated cells, and the differentiated cells are irradiated with light.
- Irradiation of differentiated adipocytes may promote lipolysis produced by adipocytes. This can be confirmed in the experimental example to be described later.
- the cocktail medium for differentiation of the present specification is not particularly limited as long as it is a medium causing a change of state from proliferation to differentiation of cells, but is not limited to FBS (fetal bovine serum), insulin (insulin), and 3-isobutyl-1-methylxanthine (IBMX )
- FBS fetal bovine serum
- insulin insulin
- IBMX 3-isobutyl-1-methylxanthine
- DEX dexamethasone
- the concentration of each inclusion can vary depending on the adipocyte differentiation conditions.
- FBS fetal bovine serum
- IBMX 3-isobutyl-1-methylxanthine
- DEX dexamethasone
- Insulin medium of the present specification serves to form fat globules (pockets) in adipocytes, and FBS medium serves to supply energy by filling fat with fat globules.
- the irradiation is not particularly limited, but is preferably performed when the adipocytes are in PBS (Phosphate Buffered Saline) medium. It is important that the wavelength of light affects the adipocytes without any special restrictions, and it is essential to apply the lipolytic effect intact through this.
- PBS Phosphate Buffered Saline
- PBS Phosphate Buffered Saline
- Non-invasive irradiation is a direct irradiation on the skin, depending on the wavelength of the irradiated light to reach the skin epidermis, the lower epidermis, the fat cells located in the shallow depth such as the dermis.
- Invasive irradiation is not particularly limited as long as it is a known invasive technique, and a deeper, for example, epidermis, is irradiated with light in the state of inserting a needle, a cannula or a microneedle or the like having a cutting surface for insertion into the skin. Light can reach the adipocytes located at a depth of 5 mm or more.
- auxiliary means that can increase the wavelength transmission force or transmittance to the adipocytes upon light irradiation according to the present specification.
- the auxiliary means can be in contact with the skin, the branched light irradiation according to the present specification may be performed through such an auxiliary means.
- the light irradiation according to the present disclosure may increase the wavelength transmission force or transmittance to the adipocytes by using a specific pattern of light that amplifies skin transmittance.
- Rat 3T3-L1 undifferentiated fibroblasts purchased from ATCC (CL-173) were prepared. Dulbecco's modified Eagle's medium (DMEM) containing 4.5 g / L glucose containing 10% calf serum (Gibco BRL, NY, USA) in a humidified incubator containing 10% CO 2 (PAA, Austria) for 2 days.
- DMEM Dulbecco's modified Eagle's medium
- the undifferentiated adipocytes obtained in the above 1-1 are differentiation cocktail medium for differentiation experiments, 10% FBS (fetal bovine serum) (PAA, Austria), 10 mg / ml insulin (Sigma-Aldrich) ), St. Louis, USA, 0.5 mM 3-isobutyl-1-methylxanthine (IBMX) (Sigma-Aldrich, St. Louis, USA), and 1 mM dexamethasone (DEX) (Sigma-Aldrich, St. Louis, USA) was replaced with DMEM containing 4.5 g / L glucose.
- FBS fetal bovine serum
- IBMX 3-isobutyl-1-methylxanthine
- DEX dexamethasone
- the medium was replaced with DMEM containing 4.5 g / L glucose containing 10% FBS and 10 mg / ml insulin and the cells were incubated for 3 days. It was then incubated in DMEM containing 4.5 g / L glucose containing 10% FBS without insulin for 2 days.
- PBS Phosphate Buffered Saline, without CaCl and MgCl
- Preadipocyte cultured undifferentiated cells obtained in 1-1 above with cocktail medium and immersed in fresh PBS again ⁇ max
- the light having a wavelength of 660 nm, 740 nm, 850 nm, 940 nm, 1,050 nm, 1,150 nm, 1,250 nm and 1,350 nm was treated for 1 hour in a humid incubator containing 10% CO 2 , respectively.
- the irradiation distance was 5 cm
- the irradiation amount was 10 J / cm 2 .
- Control (CTL) is the same for all conditions except no light treatment.
- step 4 After washing the cells cultured in insulin medium for 3 days twice with PBS, and then immersed in PBS again for 1 hour and then treated with light for the same wavelength as step 1) and exchanged with FBS medium for 2 days, and then cultured cells After washing twice with PBS, and immersed in PBS again for 1 hour, light treatment of the same wavelength as in step 1) was performed.
- the cultured cells were washed twice with PBS, and then 2% BSA (bovine serum albumin) (Sigma-Aldrich) to measure total triglyceride and glycerol eluted with medium. , St. Louis, USA) incubated for 6 hours in a limiting medium of 1,000 mg / L glucose-containing DMEM (PAA, Austria), CTL and the control group ⁇ max is 660nm, 740nm, 850nm, Culture medium was harvested from cells treated with light at wavelengths of 940 nm, 1,050 nm, 1,150 nm, 1,250 nm and 1,350 nm.
- BSA bovine serum albumin
- Adipocytes were differentiated in the same manner as in Example 1-2.
- adipocytes obtained in 2-2 in PBS for 1 hour after light treatment with wavelengths of CTL and ⁇ max of 660 nm, 740 nm, 850 nm, 940 nm, 1,050 nm, 1,150 nm, 1,250 nm and 1,350 nm, respectively. It was incubated for 6 hours in a nutritional restriction medium such as In the case of treating light, the irradiation distance was 5 cm, and the irradiation amount was 10 J / cm 2 .
- the culture medium was collected from cells treated with light having a wavelength of 660 nm, 740 nm, 850 nm, 940 nm, 1,050 nm, 1,150 nm, 1,250 nm, and 1,350 nm in the control group CTL and the experimental group ⁇ max. It was.
- the amounts of triglyceride and glycerol eluted with the nutrient-limiting medium collected after the light treatment in Examples 1 and 2 were measured using Triglyceride reagent (Sigma-Aldrich, USA) and Free Glycerol Reagent (Sigma-Aldrich, USA), respectively. Calculated. The amount of glycerol was measured by absorbance at a wavelength of 540 nm after reacting for 15 minutes by mixing the medium and Free Glycerol Reagent. The amount of eluted triglycerides was indirectly measured using lipase.
- the eluted triglyceride was decomposed into glycerol and fatty acid using lipase, and then the amount of glycerol was measured. From this measurement, only the amount of eluted triglycerides was calculated by subtracting the amount of glycerol already eluted by light treatment before lipase treatment.
- Example 1 Experimental results of Example 1 are shown in Fig. 1 and Table 1, and experimental results of Example 2 are shown in Fig. 2 and Table 2.
- Tables 1 and 2 are based on Fig. 1 and Fig. 2, respectively, showing the relative value of the result for each irradiation wavelength in percentage (%) with the control (CTL) test results in each figure as 100%.
- the numerical values of the wavelengths represent lambda max values.
- Example 1 As shown in FIG. 1 and Table 1, the results according to Example 1, it was possible to confirm the lipolysis effect at the entire wavelength treated during the light treatment during the differentiation process, in particular, eluted during the light treatment at a wavelength of 660 nm ⁇ max
- the amount of triglyceride was increased to 150.4% compared to the control group, and the amount of glycerol eluted from the medium was increased to 160.6% compared to the control group, showing the highest decomposition effect, and the wavelength with ⁇ max of 1,350 nm showing the smallest decomposition effect.
- the amount of triglycerides eluted was 139.6% higher than that of the control group, and the amount of glycerol eluted by disintegration into the medium was increased to 181.5% compared to the control group. It was confirmed. Therefore, it was confirmed that even when irradiated with light according to the present invention to the finally completed adipocytes has a very significant lipolysis effect, all these results are statistically significant.
- the amount of residual triglycerides (triglycerides) in the differentiated adipocytes was shown to be reduced at all wavelengths treated, it was confirmed that the lipolysis effect through these results. It was confirmed that the amount of residual triglycerides in adipocytes decreased by 50.3% significantly compared to the control group when light treatment with ⁇ max of 660 nm showed the highest decomposition effect, and light with wavelength of 1,350 nm showed the smallest decomposition effect. Even after treatment, the residual fat amount in adipocytes decreased to 79.8%, which was statistically significant compared to the control group. The results are all statistically significant.
- Irradiating light of a specific wavelength in the differentiation stage or the completed differentiation of adipocytes through the results of Experimental Examples 1 and 2 has a remarkable effect of degrading triglycerides in adipocytes into glycerol and neutralizing adipocytes. It can be seen that it has a significant effect on eluting fat out of cells. Therefore, it can be seen that the treatment of light according to the present invention has an effect on fat decomposition.
Abstract
Description
총 TG(%) | CTL | 100.0% |
660nm | 150.4% | |
740nm | 138.4% | |
850nm | 132.8% | |
940nm | 129.6% | |
1,050nm | 126.4% | |
1,150nm | 123.2% | |
1,250nm | 121.6% | |
1,350nm | 115.2% | |
혈청 글리세롤(SerumGlycerol)(%) | CTL | 100.0% |
660nm | 160.6% | |
740nm | 154.8% | |
850nm | 151.0% | |
940nm | 147.1% | |
1,050nm | 144.2% | |
1,150nm | 140.4% | |
1,250nm | 140.4% | |
1,350nm | 121.2% |
총 TG(%) | CTL | 100.0% |
660nm | 219.8% | |
740nm | 200.0% | |
850nm | 185.4% | |
940nm | 177.1% | |
1,050nm | 168.8% | |
1,150nm | 160.4% | |
1,250nm | 156.3% | |
1,350nm | 139.6% | |
혈청 글리세롤(SerumGlycerol)(%) | CTL | 100.0% |
660nm | 333.3% | |
740nm | 311.1% | |
850nm | 296.3% | |
940nm | 281.5% | |
1,050nm | 270.4% | |
1,150nm | 255.6% | |
1,250nm | 255.6% | |
1,350nm | 181.5% |
TG 함량 (contents)( % ) | CTL | 100.0% |
660nm | 50.3% | |
740nm | 57.0% | |
850nm | 59.6% | |
940nm | 62.2% | |
1,050nm | 62.2% | |
1,150nm | 66.8% | |
1,250nm | 69.9% | |
1,350nm | 79.8% |
Claims (19)
- 빛을 조사하는 광원 조사 장치; 및 빛을 조사하여 지방을 분해하는 방법이 포함된 설명서를 포함하는 지방 분해용 키트로서, 상기 빛은 600nm 초과 내지 1500nm 이하의 파장을 가지는 것인 키트.
- 제 1항에 있어서, 빛은 피부 투과도를 증폭시키는 패턴을 갖는 것인 키트.
- 제 1항에 있어서, 설명서는 빛의 조사세기, 빛의 조사시간, 조사장치와 피부와의 거리, 조사방법 및 조사부위를 포함하는 것인 키트.
- 제 3항에 있어서, 빛의 조사세기는 1J/cm2 내지 600J/cm2인 것인 키트.
- 제 3항에 있어서, 빛의 조사 시간은 0.5분 내지 6시간인 것인 키트.
- 제 3항에 있어서, 조사장치와 피부와의 거리는 0cm 내지 200cm인 것인 키트.
- 제 3항에 있어서, 조사 방법은 직접조사로 수행하는 것 또는 피부에 접촉될 수 있는 보조수단을 매개로 하여 수행하는 것인 키트.
- 제 7항에 있어서, 보조수단은 필터, 시트, 필름, 화장품, 젤 및 크림으로 구성된 군으로부터 선택된 하나 이상인 것인 키트.
- 제 3항에 있어서, 조사 방법은 침관, 캐뉼라, 및 마이크로 니들로 구성된 군으로부터 선택된 하나 이상을 이용하여 수행하는 것인 키트.
- 제 3항에 있어서, 조사 부위는 안구, 구강, 성기, 및 항문을 제외한 지방이 축적될 수 있는 모든 피부조직인 것인 키트.
- 피부에 빛을 조사하는 것을 포함하는 슬리밍 방법으로서,상기 빛은 600nm초과 내지 1500nm이하의 파장을 가지는 것인 슬리밍 방법.
- 제 11항에 있어서, 빛은 피부 투과도를 증폭시키는 패턴을 갖는 것인 슬리밍 방법.
- 제 11항에 있어서, 빛은 1J/cm2 내지 600J/cm2의 세기인 것인 슬리밍 방법.
- 제 11항에 있어서, 조사는 0.5분 내지 6시간 동안 조사하는 것인 슬리밍 방법.
- 제 11항에 있어서, 조사는 피부와의 거리가 0cm 내지 200cm인 위치에서 수행하는 것인 슬리밍 방법.
- 제 11항에 있어서, 조사는 직접조사로 수행하는 것 또는 피부에 접촉될 수 있는 보조수단을 매개로 하여 수행하는 것인 슬리밍 방법.
- 제 16항에 있어서, 보조수단은 필터, 시트, 필름, 화장품, 젤 및 크림으로 구성된 군으로부터 선택된 하나 이상인 것인 슬리밍 방법.
- 제 11항에 있어서, 조사는 침관, 캐뉼라, 및 마이크로 니들로 구성된 군으로부터 선택된 하나 이상을 이용하여 수행하는 것인 슬리밍 방법.
- 제 11항 내지 제 18항 중 어느 한 항에 있어서, 조사는 피부 피하지방층에 빛을 조사하는 슬리밍 방법.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/304,993 US20170181796A1 (en) | 2014-04-30 | 2015-04-28 | Kit for lipolysis by means of light radiation |
CN201580036056.5A CN106470734A (zh) | 2014-04-30 | 2015-04-28 | 用于通过光照射方式进行脂肪分解的套件 |
EP15785671.7A EP3138606A4 (en) | 2014-04-30 | 2015-04-28 | Kit for lipolysis by means of light radiation |
JP2016563412A JP2017515542A (ja) | 2014-04-30 | 2015-04-28 | 光の照射を利用した脂肪分解用キット |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2014-0052315 | 2014-04-30 | ||
KR1020140052315A KR20150125267A (ko) | 2014-04-30 | 2014-04-30 | 빛의 조사를 이용한 지방 분해용 키트 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015167213A1 true WO2015167213A1 (ko) | 2015-11-05 |
Family
ID=54358869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2015/004236 WO2015167213A1 (ko) | 2014-04-30 | 2015-04-28 | 빛의 조사를 이용한 지방 분해용 키트 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20170181796A1 (ko) |
EP (1) | EP3138606A4 (ko) |
JP (1) | JP2017515542A (ko) |
KR (1) | KR20150125267A (ko) |
CN (1) | CN106470734A (ko) |
WO (1) | WO2015167213A1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10905895B2 (en) | 2017-05-24 | 2021-02-02 | Laser Lipo Ltd. | Lipolysis radiation paddle |
CN113181556A (zh) * | 2021-04-30 | 2021-07-30 | 西北核技术研究所 | 一种增强大型效应物内场强的基于介质基底结构的辐照腔 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101996869B1 (ko) * | 2017-09-11 | 2019-07-05 | 사단법인 원텍 단국 의광학 연구센터 | 레이저를 이용한 비침습적 지방 융해 장치 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080006574A (ko) * | 2005-04-05 | 2008-01-16 | 엘.엔. 에스.피. 에이. | 레이저 지방분해 시스템 및 방법 |
KR20130095419A (ko) * | 2012-02-20 | 2013-08-28 | 이용식 | 광 조사기가 부착된 화장품용기 |
US20130268035A1 (en) * | 2012-03-05 | 2013-10-10 | Heidi Araya | System and method for reducing lipid content of adipocytes in a body |
KR20130119795A (ko) * | 2012-04-24 | 2013-11-01 | 원텍 주식회사 | 초음파와 광을 이용한 지방제거장치 |
WO2013169955A1 (en) * | 2012-05-08 | 2013-11-14 | The Regents Of The University Of California | Fine spatiotemporal control of thermolysis and lipolysis using nir light |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2403359T3 (es) * | 1998-03-27 | 2013-05-17 | The General Hospital Corporation | Procedimiento y aparato para la determinación selectiva de tejidos ricos en lípidos |
ES2325878T3 (es) * | 2000-11-03 | 2009-09-23 | Eleme Medical Inc. | Sistema para el tratamiento de tejidos. |
WO2002087700A1 (en) * | 2001-04-26 | 2002-11-07 | The Procter & Gamble Company | Method, kit and device for the treatment of cosmetic skin conditions |
CN1872007A (zh) * | 2001-05-23 | 2006-12-06 | 帕洛玛医疗技术公司 | 运作光美容装置的方法和施加电磁射线到皮肤的装置 |
US20070213698A1 (en) * | 2006-03-10 | 2007-09-13 | Palomar Medical Technologies, Inc. | Photocosmetic device |
US20030220632A1 (en) * | 2002-05-23 | 2003-11-27 | Wolfgang Strasser | Method of using gel sheets for laser treatment |
CA2576965A1 (en) * | 2004-07-16 | 2007-01-04 | Johnson & Johnson Consumer Companies, Inc. | Treatment of skin with light and a benefit agent |
WO2006093384A1 (en) * | 2005-03-02 | 2006-09-08 | Meridian Co., Ltd. | Adipose resolve apparatus for low-power laser |
EP1928549B1 (en) * | 2005-09-28 | 2014-06-11 | Candela Corporation | Apparatus for treating cellulite |
US20070197884A1 (en) * | 2006-01-24 | 2007-08-23 | Nomir Medical Technologies, Inc. | Optical method and device for modulation of biochemical processes in adipose tissue |
JP4852763B2 (ja) * | 2007-03-29 | 2012-01-11 | 国立大学法人山口大学 | 光治療器 |
JP2010005194A (ja) * | 2008-06-27 | 2010-01-14 | Fujifilm Corp | レーザ治療装置 |
US10220124B2 (en) * | 2009-02-27 | 2019-03-05 | Virginia Tech Intellectual Properties, Inc. | Fiber array for optical imaging and therapeutics |
ES2373167B1 (es) * | 2011-03-11 | 2013-01-30 | Francisco José Arriaza Muñoz | Dispositivo para el tratamiento de la celulitis. |
US8728064B2 (en) * | 2011-12-12 | 2014-05-20 | Candela Corporation | Devices for the treatment of biological tissue |
CN102784441A (zh) * | 2012-08-29 | 2012-11-21 | 深圳市瑞威康美科技有限公司 | 低功率激光脂肪分解仪的治疗仪 |
JP3180069U (ja) * | 2012-09-20 | 2012-11-29 | 清史 藤井 | 皮下脂肪分解促進装置 |
-
2014
- 2014-04-30 KR KR1020140052315A patent/KR20150125267A/ko not_active Application Discontinuation
-
2015
- 2015-04-28 WO PCT/KR2015/004236 patent/WO2015167213A1/ko active Application Filing
- 2015-04-28 JP JP2016563412A patent/JP2017515542A/ja active Pending
- 2015-04-28 EP EP15785671.7A patent/EP3138606A4/en not_active Withdrawn
- 2015-04-28 CN CN201580036056.5A patent/CN106470734A/zh active Pending
- 2015-04-28 US US15/304,993 patent/US20170181796A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080006574A (ko) * | 2005-04-05 | 2008-01-16 | 엘.엔. 에스.피. 에이. | 레이저 지방분해 시스템 및 방법 |
KR20130095419A (ko) * | 2012-02-20 | 2013-08-28 | 이용식 | 광 조사기가 부착된 화장품용기 |
US20130268035A1 (en) * | 2012-03-05 | 2013-10-10 | Heidi Araya | System and method for reducing lipid content of adipocytes in a body |
KR20130119795A (ko) * | 2012-04-24 | 2013-11-01 | 원텍 주식회사 | 초음파와 광을 이용한 지방제거장치 |
WO2013169955A1 (en) * | 2012-05-08 | 2013-11-14 | The Regents Of The University Of California | Fine spatiotemporal control of thermolysis and lipolysis using nir light |
Non-Patent Citations (1)
Title |
---|
See also references of EP3138606A4 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10905895B2 (en) | 2017-05-24 | 2021-02-02 | Laser Lipo Ltd. | Lipolysis radiation paddle |
CN113181556A (zh) * | 2021-04-30 | 2021-07-30 | 西北核技术研究所 | 一种增强大型效应物内场强的基于介质基底结构的辐照腔 |
CN113181556B (zh) * | 2021-04-30 | 2022-09-23 | 西北核技术研究所 | 一种增强大型效应物内场强的基于介质基底结构的辐照腔 |
Also Published As
Publication number | Publication date |
---|---|
JP2017515542A (ja) | 2017-06-15 |
US20170181796A1 (en) | 2017-06-29 |
KR20150125267A (ko) | 2015-11-09 |
CN106470734A (zh) | 2017-03-01 |
EP3138606A4 (en) | 2017-12-20 |
EP3138606A1 (en) | 2017-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dougherty et al. | Photoradiation therapy—clinical and drug advances | |
CN102600057B (zh) | 人胎盘干细胞提取物冻干粉及其制备方法与应用 | |
CN102861379B (zh) | 新生儿黄疸治疗系统 | |
WO2015167213A1 (ko) | 빛의 조사를 이용한 지방 분해용 키트 | |
CN201085852Y (zh) | 红外偏振光治疗仪 | |
CN102179011B (zh) | 红外线-中波紫外线治疗仪 | |
WO2004028353A3 (en) | Optical apparatus for guided liver tumor treatment and methods | |
WO2005123189A3 (en) | Methods and apparatus for stabilizing a subject undergoing phototherapy treatment | |
WO2018008801A1 (ko) | 플라즈마 및 근적외선을 이용한 피부 미용 장치 | |
Tanaka et al. | Beneficial applications and deleterious effects of near-infrared from biological and medical perspectives | |
CN101822872A (zh) | 一种眼近红外光治疗仪 | |
DE50103801D1 (de) | Vorrichtung zur akupunktur mittels laserstrahlung | |
JP2024037928A (ja) | 光老化及び/又は真皮色素沈着を予防及び/又は改善するための方法,装置,および抗光老化及び/又は真皮色素沈着抑制剤,抗光老化及び/又は真皮色素沈着抑制剤のスクリーニング方法,抗光老化及び/又は真皮色素沈着抑制美容処置の評価方法,並びに光老化及び/又は真皮色素沈着度の評価方法 | |
Tanaka et al. | The impact of near-infrared in plastic surgery | |
WO2013180421A1 (ko) | 저주파 및 광 치료용 마스크 | |
CN202052211U (zh) | 蓝光毯 | |
CN106377846B (zh) | 立式led光疗皮肤护理仪 | |
WO2021080230A1 (ko) | 수면유도장치 및 상기 장치를 이용한 수면유도방법 | |
CN108542762A (zh) | 一种便携头戴式中医理疗耳灸仪器 | |
Suckow et al. | Influence of 627 nm wavelength light emitting diode phototherapy on secondary inten-tion wound healing | |
WO2015160056A1 (ko) | 광흡수 증대 효과가 우수한 피부 미용 광반응 조성물 | |
CN204364690U (zh) | 直线偏振光疼痛治疗仪 | |
WO2022114481A1 (ko) | 피부질환 치료 장치 및 이를 포함하는 피부질환 치료 시스템 | |
WO2023074976A1 (ko) | 광선 치료기기 | |
CN116473856A (zh) | 一种美白亮肤面膜精华液及其制备方法、一种美白亮肤面膜 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15785671 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 15304993 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2016563412 Country of ref document: JP Kind code of ref document: A |
|
REEP | Request for entry into the european phase |
Ref document number: 2015785671 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2015785671 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |